TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 1
on
COMPELETE TESTBANK K
TESTBANK FOR CLAYON’S BASIC PHARMACOLOGY F
K K K K K
OR NURSES 19TH EDITION/ WILLIHNGANZ VERIFIEDQ
K K K K K K
UESTIONS AND ANSWERS WITH 2024 UPDATES (ALLC
K K K K K K K
HAPTERS INLUDED 1-48) K K
,TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 2
on
Chapter 01: Drug Definitions, Standards, and Information Sources
K K K K K K K
KWillihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Editi
K K K K K K K
on
1. WhichKnameKidentifiesKaKdrugKlistedKbyKtheKUSKFoodKDru
gKAdministrationK(FDA)?
a. Bran
b. Nonproprietar
c. Official
d. Trademark
ANS:
TheKofficialKnameKisKtheKnameKunderKwhichKaKdrugKisKlistedKby
KtheK FDA.K TheK brandK name,K orK trademark,K isK theK nameK givenK
toKaKdrugKbyKitsKmanufacturer.KTheKnonproprietary,KorKgeneric,K
nameKisKprovidedKbyKtheKUnitedKStatesKAdoptedKNamesKCoun
cil.
CognitiveKLevel:KKnowledge REF:K p.K9
OBJ:K1NAT:KNCLEXKClientKNeedsKCategory:KSafe,KEffectiveKCa
reKEnvironmentKTOP:K NursingKProcessKStep:KAssessment
CON:K
PatientKEducation
2. WhichKsourceKcontainsKinformationKspecificKtoKnutritionalKsupplements?
a. USPKDictionaryKofKUSANK &KInternationalKDrugKNames
b. NaturalKMedicinesKComprehensiveKDatabase
c. UnitedKStatesKPharmacopoeia/NationalKFormularyK(USPKNF)
d. DrugKInteractionKFacts
ANS:K C
UnitedKStatesKPharmacopoeia/NationalKFormularyKcontainsKinformationKspecificKtoKnutritiona
lKsupplements.KUSPKDictionaryKofKUSANK&KInternationalKDrugKNamesKisKaKcompilationKofKdr
ugKnames,KpronunciationKguide,KandKpossibleKfutureKFDAKapprovedKdrugs;KitKdoesKnotKinclude
KnutritionalKsupplements.KNaturalKMedicinesKComprehensiveKDatabaseKcontains
evidence-
basedKinformationKonKherbalKmedicinesKandKherbalKcombinationKproducts;KitKdoesKnotKincludeKi
nformationKspecificKtoKnutritionalKsupplements.KDrugKInteractionKFactsKcontainsKcomprehens
iveKinformationKonKdrugKinteractionKfacts;KitKdoesKnotKincludeKnutritionalKsupplements.
DIF: CognitiveKLevel:KKnowledge REF:K p.K4
OBJ:K3KNAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKInte
grity
TOP:K NursingKProcessKStep:KAssessment CON:K NutritionK|KPatientKEducation
3. WhichKdrugKreferenceKcontainsKdrugKmonographsKthatKdescribeKallKdrugsKinKaKtherapeuticKclass?
a. DrugKFactsKandKComparisons
,TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 3
on
b. DrugKInteractionKFacts
c. HandbookKonKInjectableKDrugs
d. Martindale—TheKCompleteKDrugKReference
ANS:K A
DrugKFactsKandKComparisonsKcontainsKdrugKmonographsKthatKdescribeKallKdrugsKinKaK
therapeuticKclass.KMonographsKareKformattedKasKtablesKtoKallowKcomparisonKofKsimilarK
products,KbrandKnames,Kmanufacturers,KcostKindices,KandKavailableKdosageKformsKOnl
ineKversionKisKavailable.
DIF: CognitiveKLevel:KKnowledge REF:K p.K4KTableK1.2
OBJ:KKK 3 NAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKIntegrity
TOP:K NursingKProcessKStep:KAssessment CON:K SafetyK|KPatientKEducationK|KClinicalKJudgment
4. WhichKdrugKreferenceKcontainsKmonographsKaboutKvirtuallyKeveryKsingle-
entityKdrugKavailableKinKtheKUnitedKStatesKandKdescribesKtherapeuticKusesKofKdrugs,Kincluding
KapprovedKandKunapprovedKuses?
a. Martindale:KTheKCompleteKDrugKReference
b. AHFSKDrugKInformation
c. DrugKReference
d. DrugKFactsKandKComparisons
ANS:K B
AHFSKDrugKInformationKcontainsKmonographsKaboutKvirtuallyKeveryKsingle-
entityKdrugKavailableKinKtheKUnitedKStatesKandKdescribesKtherapeuticKusesKofKdrugs,KincludingKa
pprovedKandKunapprovedKuses.
DIF: CognitiveKLevel:KKnowledge REF:K p.K4KTableK1.2
OBJ:KKK 3 NAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKIntegrity
TOP:K NursingKProcessKStep:KPlanning CON:K SafetyK|KPatientKEducationK|KClinicalKJudgment
5. WhichKonlineKdrugKreferenceKmakesKavailableKtoKhealthcareKprovidersKandKtheKpublicKaKst
andard,Kcomprehensive,Kup-to-dateKlookKupKandKdownloadableKresourceKaboutKmedicines?
a. AmericanKDrugKIndex
b. AmericanKHospitalKFormulary
c. DailyMed
d. DrugKReference
ANS:K C
DailyMedKmakesKavailableKtoKhealthcareKprovidersKandKtheKpublicKaKstandard,Kcomprehensiv
e,Kup-to-
dateKlookKupKandKdownloadableKresourceKaboutKmedicines.KTheKAmericanKDrugKIndexKisKnotK
appropriateKforKpatientKuse.KTheKAmericanKHospitalKFormularyKisKnotKappropriateKforKpatien
tKuse.KTheKdrugKreferenceKisKnotKappropriateKforKpatientKuse.
DIF: CognitiveKLevel:KKnowledge REF:K p.K3K|Kp.K4
OBJ:K3KNAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKInte
grity
TOP:K NursingKProcessKStep:KImplementation
CON:K SafetyK|KPatientKEducationK|KClinicalKJudgment
6. WhichKlegislationKauthorizesKtheKFDAKtoKdetermineKtheKsafetyKofKaKdrugKbeforeKitsKmarketing?
a. FederalKFood,KDrug,KandKCosmeticKActK(1938)
b. DurhamKHumphreyKAmendmentK(1952)
, TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 4
on
c. ControlledKSubstancesKActK(1970)
d. KefauverKHarrisKDrugKAmendmentK(1962)
ANS:K A
TheKFederalKFood,KDrug,KandKCosmeticKActKofK1938KauthorizedKtheKFDAKtoKdetermineKtheKsa
fetyKofKallKdrugsKbeforeKmarketing.KLaterKamendmentsKandKactsKhelpedKtightenKFDAKcontrolK
andKensureKdrugKsafety.KTheKDurhamKHumphreyKAmendmentKdefinesKtheKkindsKofKdrugsKthat
KcannotKbeKusedKsafelyKwithoutKmedicalKsupervisionKandKrestrictsKtheirKsaleKtoKprescriptionKby
KaKlicensedKpractitioner.KTheKControlledKSubstances KActKaddressesKonlyKcontrolledKsubstancesK
andKtheirKcategorization.KTheKKefauverKHarrisKDrugKAmendmentKensuresKdrugKefficacyKandKgr
eaterKdrugKsafety.KDrugKmanufacturersKareKrequiredKtoKproveKtoKtheKFDAKtheKeffectivenessKofK
theirKproductsKbeforeKmarketingKthem.
DIF: CognitiveKLevel:KKnowledge REF:Kp.K5KTableKl.3
OBJ:K 5
NAT:KNCLEXKClientKNeedsKCategory:KPhysiologicalKIntegrit
yKTOP:K NursingKProcessKStep:KAssessment
CON:K SafetyK|KPatientKEducationK|KEvidenceK|KHealthKCareKLaw
7. WhichKclassificationKdoesKmeperidineK(Demerol)KfallKunder?
a. I
b. II
c. III
d. IV
ANS:K B
MeperidineK(Demerol)KisKaKScheduleKIIKdrug;KitKhasKaKhighKpotentialKforKabuseKandKmayKleadK
toKsevereKpsychologicalKandKphysicalKdependence.KScheduleKIKdrugsKhaveKhighKpotentialKforKab
useKandKnoKrecognizedKmedicalKuse.KScheduleKIIIKdrugsKhaveKsomeKpotentialKforKabuse.KUseK
mayKleadKtoKlowKtoKmoderateKphysicalKdependenceKorKhighKpsychologicalKdependence.KSched
uleKIVKdrugsKhaveKlowKpotentialKforKabuse.KUseKmayKleadKtoKlimitedKphysicalKorKpsychologica
lKdependence.
DIF: CognitiveKLevel:KKnowledge REF:K p.K10
OBJ:K2KNAT:K NCLEXKClientKNeedsKCategory:KSafe,KEffectiveKCa
reKEnvironment
TOP:K NursingKProcessKStep:KAssessment CON:K PatientKEducationK|KAddictionK|KPain
8. WhichKactionKwouldKtheKFDAKtakeKtoKexpediteKdrugKdevelopmentKandKapprovalKforKanKoutbre
akKofKsmallpox?
a. ListKsmallpoxKasKaKhealthKorphanKdisease.
b. OmitKtheKpreclinicalKresearchKphase.
c. ExtendKtheKclinicalKresearchKphase.
d. FastKtrackKtheKinvestigationalKdrug.
ANS:K D
OnceKtheKInvestigationalKNewKDrugKApplicationKhasKbeenKapproved,KtheKdrugKcanKreceiveKhi
ghestKpriorityKwithinKtheKagency,KwhichKisKcalledKfastKtracking.KAKsmallpoxKoutbreakKwouldK
becomeKaKpriorityKconcernKinKtheKworld.KOrphanKdiseasesKareKnotKresearchedKinKaKpriorityKma
nner.KPreclinicalKresearchKisKnotKomitted.KExtendingKanyKphaseKofKtheKresearchKwouldKmeanKa
KlongerKtimeKtoKdevelopKaKvaccine.KTheKFDAKmustKensureKthatKallKphasesKofKtheKpreclinicalKan
dKclinicalKresearchKphaseKhaveKbeenKcompletedKinKaKsafeKmanner.
DIF: CognitiveKLevel:KKnowledge REF:K p.K7 OBJ:K 5
on
COMPELETE TESTBANK K
TESTBANK FOR CLAYON’S BASIC PHARMACOLOGY F
K K K K K
OR NURSES 19TH EDITION/ WILLIHNGANZ VERIFIEDQ
K K K K K K
UESTIONS AND ANSWERS WITH 2024 UPDATES (ALLC
K K K K K K K
HAPTERS INLUDED 1-48) K K
,TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 2
on
Chapter 01: Drug Definitions, Standards, and Information Sources
K K K K K K K
KWillihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Editi
K K K K K K K
on
1. WhichKnameKidentifiesKaKdrugKlistedKbyKtheKUSKFoodKDru
gKAdministrationK(FDA)?
a. Bran
b. Nonproprietar
c. Official
d. Trademark
ANS:
TheKofficialKnameKisKtheKnameKunderKwhichKaKdrugKisKlistedKby
KtheK FDA.K TheK brandK name,K orK trademark,K isK theK nameK givenK
toKaKdrugKbyKitsKmanufacturer.KTheKnonproprietary,KorKgeneric,K
nameKisKprovidedKbyKtheKUnitedKStatesKAdoptedKNamesKCoun
cil.
CognitiveKLevel:KKnowledge REF:K p.K9
OBJ:K1NAT:KNCLEXKClientKNeedsKCategory:KSafe,KEffectiveKCa
reKEnvironmentKTOP:K NursingKProcessKStep:KAssessment
CON:K
PatientKEducation
2. WhichKsourceKcontainsKinformationKspecificKtoKnutritionalKsupplements?
a. USPKDictionaryKofKUSANK &KInternationalKDrugKNames
b. NaturalKMedicinesKComprehensiveKDatabase
c. UnitedKStatesKPharmacopoeia/NationalKFormularyK(USPKNF)
d. DrugKInteractionKFacts
ANS:K C
UnitedKStatesKPharmacopoeia/NationalKFormularyKcontainsKinformationKspecificKtoKnutritiona
lKsupplements.KUSPKDictionaryKofKUSANK&KInternationalKDrugKNamesKisKaKcompilationKofKdr
ugKnames,KpronunciationKguide,KandKpossibleKfutureKFDAKapprovedKdrugs;KitKdoesKnotKinclude
KnutritionalKsupplements.KNaturalKMedicinesKComprehensiveKDatabaseKcontains
evidence-
basedKinformationKonKherbalKmedicinesKandKherbalKcombinationKproducts;KitKdoesKnotKincludeKi
nformationKspecificKtoKnutritionalKsupplements.KDrugKInteractionKFactsKcontainsKcomprehens
iveKinformationKonKdrugKinteractionKfacts;KitKdoesKnotKincludeKnutritionalKsupplements.
DIF: CognitiveKLevel:KKnowledge REF:K p.K4
OBJ:K3KNAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKInte
grity
TOP:K NursingKProcessKStep:KAssessment CON:K NutritionK|KPatientKEducation
3. WhichKdrugKreferenceKcontainsKdrugKmonographsKthatKdescribeKallKdrugsKinKaKtherapeuticKclass?
a. DrugKFactsKandKComparisons
,TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 3
on
b. DrugKInteractionKFacts
c. HandbookKonKInjectableKDrugs
d. Martindale—TheKCompleteKDrugKReference
ANS:K A
DrugKFactsKandKComparisonsKcontainsKdrugKmonographsKthatKdescribeKallKdrugsKinKaK
therapeuticKclass.KMonographsKareKformattedKasKtablesKtoKallowKcomparisonKofKsimilarK
products,KbrandKnames,Kmanufacturers,KcostKindices,KandKavailableKdosageKformsKOnl
ineKversionKisKavailable.
DIF: CognitiveKLevel:KKnowledge REF:K p.K4KTableK1.2
OBJ:KKK 3 NAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKIntegrity
TOP:K NursingKProcessKStep:KAssessment CON:K SafetyK|KPatientKEducationK|KClinicalKJudgment
4. WhichKdrugKreferenceKcontainsKmonographsKaboutKvirtuallyKeveryKsingle-
entityKdrugKavailableKinKtheKUnitedKStatesKandKdescribesKtherapeuticKusesKofKdrugs,Kincluding
KapprovedKandKunapprovedKuses?
a. Martindale:KTheKCompleteKDrugKReference
b. AHFSKDrugKInformation
c. DrugKReference
d. DrugKFactsKandKComparisons
ANS:K B
AHFSKDrugKInformationKcontainsKmonographsKaboutKvirtuallyKeveryKsingle-
entityKdrugKavailableKinKtheKUnitedKStatesKandKdescribesKtherapeuticKusesKofKdrugs,KincludingKa
pprovedKandKunapprovedKuses.
DIF: CognitiveKLevel:KKnowledge REF:K p.K4KTableK1.2
OBJ:KKK 3 NAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKIntegrity
TOP:K NursingKProcessKStep:KPlanning CON:K SafetyK|KPatientKEducationK|KClinicalKJudgment
5. WhichKonlineKdrugKreferenceKmakesKavailableKtoKhealthcareKprovidersKandKtheKpublicKaKst
andard,Kcomprehensive,Kup-to-dateKlookKupKandKdownloadableKresourceKaboutKmedicines?
a. AmericanKDrugKIndex
b. AmericanKHospitalKFormulary
c. DailyMed
d. DrugKReference
ANS:K C
DailyMedKmakesKavailableKtoKhealthcareKprovidersKandKtheKpublicKaKstandard,Kcomprehensiv
e,Kup-to-
dateKlookKupKandKdownloadableKresourceKaboutKmedicines.KTheKAmericanKDrugKIndexKisKnotK
appropriateKforKpatientKuse.KTheKAmericanKHospitalKFormularyKisKnotKappropriateKforKpatien
tKuse.KTheKdrugKreferenceKisKnotKappropriateKforKpatientKuse.
DIF: CognitiveKLevel:KKnowledge REF:K p.K3K|Kp.K4
OBJ:K3KNAT:K NCLEXKClientKNeedsKCategory:KPhysiologicalKInte
grity
TOP:K NursingKProcessKStep:KImplementation
CON:K SafetyK|KPatientKEducationK|KClinicalKJudgment
6. WhichKlegislationKauthorizesKtheKFDAKtoKdetermineKtheKsafetyKofKaKdrugKbeforeKitsKmarketing?
a. FederalKFood,KDrug,KandKCosmeticKActK(1938)
b. DurhamKHumphreyKAmendmentK(1952)
, TestKBankKForKClayton’sKBasicKPharmacologyKforKNursesK19thKEditi 4
on
c. ControlledKSubstancesKActK(1970)
d. KefauverKHarrisKDrugKAmendmentK(1962)
ANS:K A
TheKFederalKFood,KDrug,KandKCosmeticKActKofK1938KauthorizedKtheKFDAKtoKdetermineKtheKsa
fetyKofKallKdrugsKbeforeKmarketing.KLaterKamendmentsKandKactsKhelpedKtightenKFDAKcontrolK
andKensureKdrugKsafety.KTheKDurhamKHumphreyKAmendmentKdefinesKtheKkindsKofKdrugsKthat
KcannotKbeKusedKsafelyKwithoutKmedicalKsupervisionKandKrestrictsKtheirKsaleKtoKprescriptionKby
KaKlicensedKpractitioner.KTheKControlledKSubstances KActKaddressesKonlyKcontrolledKsubstancesK
andKtheirKcategorization.KTheKKefauverKHarrisKDrugKAmendmentKensuresKdrugKefficacyKandKgr
eaterKdrugKsafety.KDrugKmanufacturersKareKrequiredKtoKproveKtoKtheKFDAKtheKeffectivenessKofK
theirKproductsKbeforeKmarketingKthem.
DIF: CognitiveKLevel:KKnowledge REF:Kp.K5KTableKl.3
OBJ:K 5
NAT:KNCLEXKClientKNeedsKCategory:KPhysiologicalKIntegrit
yKTOP:K NursingKProcessKStep:KAssessment
CON:K SafetyK|KPatientKEducationK|KEvidenceK|KHealthKCareKLaw
7. WhichKclassificationKdoesKmeperidineK(Demerol)KfallKunder?
a. I
b. II
c. III
d. IV
ANS:K B
MeperidineK(Demerol)KisKaKScheduleKIIKdrug;KitKhasKaKhighKpotentialKforKabuseKandKmayKleadK
toKsevereKpsychologicalKandKphysicalKdependence.KScheduleKIKdrugsKhaveKhighKpotentialKforKab
useKandKnoKrecognizedKmedicalKuse.KScheduleKIIIKdrugsKhaveKsomeKpotentialKforKabuse.KUseK
mayKleadKtoKlowKtoKmoderateKphysicalKdependenceKorKhighKpsychologicalKdependence.KSched
uleKIVKdrugsKhaveKlowKpotentialKforKabuse.KUseKmayKleadKtoKlimitedKphysicalKorKpsychologica
lKdependence.
DIF: CognitiveKLevel:KKnowledge REF:K p.K10
OBJ:K2KNAT:K NCLEXKClientKNeedsKCategory:KSafe,KEffectiveKCa
reKEnvironment
TOP:K NursingKProcessKStep:KAssessment CON:K PatientKEducationK|KAddictionK|KPain
8. WhichKactionKwouldKtheKFDAKtakeKtoKexpediteKdrugKdevelopmentKandKapprovalKforKanKoutbre
akKofKsmallpox?
a. ListKsmallpoxKasKaKhealthKorphanKdisease.
b. OmitKtheKpreclinicalKresearchKphase.
c. ExtendKtheKclinicalKresearchKphase.
d. FastKtrackKtheKinvestigationalKdrug.
ANS:K D
OnceKtheKInvestigationalKNewKDrugKApplicationKhasKbeenKapproved,KtheKdrugKcanKreceiveKhi
ghestKpriorityKwithinKtheKagency,KwhichKisKcalledKfastKtracking.KAKsmallpoxKoutbreakKwouldK
becomeKaKpriorityKconcernKinKtheKworld.KOrphanKdiseasesKareKnotKresearchedKinKaKpriorityKma
nner.KPreclinicalKresearchKisKnotKomitted.KExtendingKanyKphaseKofKtheKresearchKwouldKmeanKa
KlongerKtimeKtoKdevelopKaKvaccine.KTheKFDAKmustKensureKthatKallKphasesKofKtheKpreclinicalKan
dKclinicalKresearchKphaseKhaveKbeenKcompletedKinKaKsafeKmanner.
DIF: CognitiveKLevel:KKnowledge REF:K p.K7 OBJ:K 5
